Literature DB >> 11529433

A prospective study of sensitivity and specificity of adenosine deaminase estimation in the diagnosis of tuberculosis pleural effusion.

S K Sharma1, V Suresh, A Mohan, P Kaur, P Saha, A Kumar, J N Pande.   

Abstract

We prospectively evaluated the usefulness of adenosine deaminase [ADA] estimation in the diagnosis of tuberculosis [TB] pleural effusion. Seventy five subjects with pleural effusion were studied. Forty eight of them had TB pleural effusion [M:F: 37:11; mean age 33 +/- 14.4 years range 17-76] and the remaining 27 had pleural effusion due to causes other than TB [non-TB group] [M:F: 19:8; mean age 47.3 +/- 16.5 years; range 17-75]. Pleural fluid [PF] ADA levels were significantly higher in TB (n=48; mean 95.8 +/- 57.5 IU/L) compared with non-TB group (n=27; mean 30.7 +/- 27.2 IU/L) [p<0.001]. Serum ADA [S-ADA] levels were also significantly higher in TB (n=45; mean 39.6 +/- 18.3 IU/L) compared with non-TB group (n=26; mean 18.0 +/- 13.7 IU/L) [p<0.001]. PF-ADA levels were higher compared to S-SDA in TB (p <0.001) and non-TB groups [p<0.01]. Using a cut off of 35 IU/L, the sensitivity and specificity of PF-ADA in the diagnosis of TB was computed to be 83.3% and 66.6% respectively. At a cut-off level of 100 IU/L, PF-ADA was found to have a sensitivity 40% and specificity 100%. From this study it is concluded that, using 100 IU/L as the cut-off, it is possible to avoid pleural biopsy to ascertain the diagnosis of TB in as much as 40% of the patients.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11529433

Source DB:  PubMed          Journal:  Indian J Chest Dis Allied Sci        ISSN: 0377-9343


  14 in total

1.  Pleural fluid interferon-gamma and adenosine deaminase levels in tuberculosis pleural effusion: a cost-effectiveness analysis.

Authors:  S K Sharma; Amit Banga
Journal:  J Clin Lab Anal       Date:  2005       Impact factor: 2.352

2.  Assessment of the N-PCR assay in diagnosis of pleural tuberculosis: detection of M. tuberculosis in pleural fluid and sputum collected in tandem.

Authors:  Parameet Kumar; Manas K Sen; Devendra S Chauhan; Vishwa M Katoch; Sarman Singh; Hanumanthappa K Prasad
Journal:  PLoS One       Date:  2010-04-19       Impact factor: 3.240

3.  Alkaline phosphatase: Distinguishing between tuberculous and nontuberculous pleural effusion.

Authors:  Ashish Anantrao Jadhav; Jayashree Suhas Bardapurkar; Anuradha Jain
Journal:  Lung India       Date:  2009-07

4.  Markers for differentiation of tubercular pleural effusion from non-tubercular effusion.

Authors:  Vivek Ambade; M M Arora; S P Rai; S K Nikumb; D R Basannar
Journal:  Med J Armed Forces India       Date:  2011-10-22

5.  Diagnostic Yield of Closed Pleural Biopsy in Undiagnosed Exudative Pleural Effusions.

Authors:  Kaushik Saha; Arnab Maji; Ankan Bandyopadhyay; Debraj Jash
Journal:  Maedica (Bucur)       Date:  2021-03

6.  A rare presentation of splenic tuberculosis with a pseudocyst.

Authors:  Kalyan Chakradhar; Shiva Prasad; Sampath Kumar; Manna Valiathan
Journal:  BMJ Case Rep       Date:  2014-05-13

7.  Diagnosis and management of miliary tuberculosis: current state and future perspectives.

Authors:  Sayantan Ray; Arunansu Talukdar; Supratip Kundu; Dibbendhu Khanra; Nikhil Sonthalia
Journal:  Ther Clin Risk Manag       Date:  2013-01-08       Impact factor: 2.423

Review 8.  Challenges in the diagnosis & treatment of miliary tuberculosis.

Authors:  Surendra K Sharma; Alladi Mohan; Abhishek Sharma
Journal:  Indian J Med Res       Date:  2012-05       Impact factor: 2.375

9.  Role of percutaneous closed needle pleural biopsy among patients of undiagnosed exudative pleural effusion.

Authors:  H S Hira; Rajiv Ranjan
Journal:  Lung India       Date:  2011-04

10.  Adenosine deaminase activity is a sensitive marker for the diagnosis of tuberculous pleuritis in patients with very low CD4 counts.

Authors:  Kamaldeen Baba; Anwar A Hoosen; Nina Langeland; Anne M Dyrhol-Riise
Journal:  PLoS One       Date:  2008-07-30       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.